Controversies on neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy

Overview of attention for article published in British Journal of Ophthalmology, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 3 X users

patent: 4 patents

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,554 followers.

Controversies on neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy https://t.co/aByGAMWlQ0 #bmj #oftalmologia #ophthalmology

Looking for prof. Sohan Hayreh's Sept 2019 reaction on using neuroprotectors like Quark Pharmaceuiticals QPI1007 and Regenera's RpH201? Here it is. He is the father of #naaion #naaion research so worth every bit reading his ideas. See https://t.co/n3hNL…

Ophthopedia Update: Controversies on neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy https://t.co/jtSqS6TONA #Ophthalmology #Ophthotwitter #BJO https://t.co/OOZTfVMMzN

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.